Moss Adams Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
5,205
+483
+10% +$26.2K 0.01% 275
2026
Q1
$296K Sell
4,722
-980
-17% -$78.4K 0.02% 207
2025
Q4
$544K Sell
5,702
-434
-7% -$42.5K 0.04% 125
2025
Q3
$599K Buy
6,136
+45
+0.7% +$4.66K 0.05% 117
2025
Q2
$654K Buy
6,091
+1,526
+33% +$154K 0.06% 111
2025
Q1
$461K Buy
4,565
+1,170
+34% +$118K 0.05% 115
2024
Q4
$303K Buy
3,395
+337
+11% +$29.7K 0.03% 146
2024
Q3
$256K Buy
+3,058
New +$241K 0.03% 165

Other funds holding BSX

Moss Adams Wealth Advisors's BSX Position: Q2 2026 in Review

Moss Adams Wealth Advisors increased its Boston Scientific (BSX) stake by 10% in Q2 2026, buying an estimated $26.2K and bringing the position to 5,205 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #275.

Moss Adams Wealth Advisors first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $654K in Q2 2025. 388 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Moss Adams Wealth Advisors held 5,205 shares of Boston Scientific worth $222K as of Q2 2026.
  • Moss Adams Wealth Advisors bought 483 Boston Scientific shares in Q2 2026, an estimated $26.2K.
  • Boston Scientific made up 0.01% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #275 holding.
  • Moss Adams Wealth Advisors first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Moss Adams Wealth Advisors's Boston Scientific position peaked at $654K in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.